DOI:
10.1055/s-00000034
Klinische Pädiatrie
Issue 04 ·
Volume 204 ·
July 1992
DOI: 10.1055/s-002-10298
Accepted Manuscripts
eFirst
Issue
Most Read
189
198
Boos, J.:
The Pharmacokinetics of Cytarabine - Is it Clinically Relevant?
214
Schweinitz, D. von;
Bürger, D.;
Weinel, P.;
Mildenberger, H.:
The Treatment of Malignant Liver Tumours in Childhood
221
Zintl, F.;
Malke, H.;
Reimann, M.;
Hermann, J.;
Domula, M.;
Dörffel, W.;
Eggers, G.;
Exadaktylos, P.;
Hilgenfeld, E.;
Kotte, W.;
Krause, I.;
Kunert, W.;
Mittler, U.;
Möbius, D.;
Reddemann, H.;
Weißbach, G.;
Weinmann, G.:
Experiences with Modified BFM-Protocols in Children with Acute Lymphoblastic Leukemia (ALL) in East German States from 1981 to 1991
230
Gobrecht, O.;
Göbel, U.;
Graubner, U.;
Gutjahr, P.;
Schöck, V.;
Spaar, H.-J.;
Janka-Schaub, G. E.:
Influence of Individual Dose Intensity in Intensive Therapy on Prognosis in Childhood Acute Lymphoblastic Leukemia
236
Creutzig, U.;
Ritter, J.;
Heyen, P.;
Berthold, F.;
Henze, G.;
Kabisch, H.;
Lampert, F.;
Niethammer, D.;
Riehm, H.;
Schellong, G.:
Influence of Cranial Irradiation on the Relapse Rate in Children with Acute Myelogenous Leukemia
246
Creutzig, Ursula;
Bender-Götze, Christine;
Klingebiel, Th.;
Ebell, W.;
Friedrich, W.;
Stollmann-Gibbels, Brigitte;
Schmidt, H.;
Suttorp, M.;
Gratwohl, A.;
Heyen, Petra;
Ritter, J.;
Schellong, G.:
Comparison of Postremission Chemotherapy and Allogeneic Bone Marrow Transplantation in First Complete Remission in Children with Acute Myelogenous Leukemia in Studies AML-BFM-83 and AML-BFM-87. Matched Pair Analysis
253
Stahnke, K.;
Ritter, J.;
Schellong, G.;
Beck, J. D.;
Kabisch, H.;
Lampert, F.;
Creutzig, U.:
Treatment of Relapsed Acute Myelogenous Leukemia in Childhood after Pretreatment with the AML-BFM-83 Protocol
258
Kohne, E.;
Stahnke, K.;
Kulozik, A. E.;
Kleihauer, E.:
German Thalassaemia Multi-Center Study
274
Schwinger, W.;
Urban, Ch.;
Lackner, H.:
Treatmant and Further Prophylaxis of L-Asparaginase-Induced Anaphylaxis with a Concomittant Epinephrine Infusion
277
Schneeweiß, H.;
Berthold, F.:
The Determination of Immunoglobulin G Subclasses in Children and Adolescents with Malignant Diseases
288
Berthold, F.;
Sander, J.;
Baillot, A.;
Hunneman, D. H.;
Michaelis, J.:
Neuroblastoma Screening Project "Niedersachsen/Nordrhein-Westfalen": The Necessity of an Epidemiological Comparison
299
Boos, J.;
Welslau, U.;
Ritter, J.;
Blaschke, G.;
Schellong, G.:
Ifosfamide and its 'Side Chain Oxidized' Metabolites - Urinary Excretion under Different Pediatric Treatment Schedules
Übersichten
190
Niemeyer, C.;
Stollmann-Gibbels, B.;
Ebell, W.;
Gaedicke, G.;
Creutzig, U.:
Myelodysplasia in Childhood
Therapiestudien
204
Ludwig, R.;
Weirich, A.;
Pötter, R.;
Harms, D.;
Bürger, D.;
Michaelis, J.;
Erttmann, R.;
Weinel, P.;
Haas, R. J.;
Ritter, J.;
Jakobi, H.:
Pre-operative Chemotherapy of Nephroblastoma
Nebenwirkungen
264
Sutor, A. H.;
Niemeyer, C.;
Sauter, S.;
Witt, I.;
Kaufmehl, K.;
Rombach, A.;
Brandis, M.;
Riehm, H.:
Alteration of Hemostasis with the Treatment Protocols ALL-BFM 90 and NHL-BFM 90
Neuroblastom-Screening
282
Schilling, F. H.;
Erttmann, R.;
Dohrmann, S.;
Erb, N.;
Winkler, K.;
Groß, U.;
Treuner, J.:
Early Detection of Neuroblastoma in Germany
Kliniknahe Grundlagenforschung
293
Bökkerink, J. P. M.;
De Abreu, R. A.;
Stet, E. H.;
Damen, F. J. M.:
Zellkinetik und biochemische Pharmakologie von Methotrexat und 6-Merkaptopurin in menschlichen malignen T-Lymphoblasten